Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease

NCT05709301 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease
Mild Cognitive Impairment

Interventions

DRUG: Donepezil Hydrochloride
DRUG: Placebo

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau